Dogwood Therapeutics Raises $5 Million in Share Sale at $1.22
The company agreed to sell 4,098,360 common shares to Sealbond for approximately $5 million in gross proceeds. Closing is expected on or before Oct. 29, 2026.
Dogwood Therapeutics entered into two related agreements with Sealbond to strengthen liquidity and support future flexibility. The company agreed to sell 4,098,360 common shares at $1.22 per share for approximately $5 million in gross proceeds, with closing expected on or before Oct 29, 2026. Concu…